(Q33742289)

29 July 2017

title

Evaluation of teicoplanin for treatment of endocarditis caused by gram-positive cocci in 20 patients (English)

1 reference

29 July 2017

main subject

gram-positive bacteria

0 references

author name string

Leport C

1

1 reference

29 July 2017

Perronne C

2

1 reference

29 July 2017

Massip P

3

1 reference

29 July 2017

Canton P

4

1 reference

29 July 2017

Leclercq P

5

1 reference

29 July 2017

Bernard E

6

1 reference

29 July 2017

Lutun P

7

1 reference

29 July 2017

Garaud JJ

8

1 reference

29 July 2017

Vilde JL

9

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 June 1989

1 reference

Antimicrobial Agents and Chemotherapy

29 July 2017

published in

1 reference

29 July 2017

volume

33

1 reference

29 July 2017

issue

6

1 reference

29 July 2017

page(s)

871-876

1 reference

Infective endocarditis: an analysis based on strict case definitions

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284248

Clinical significance of tolerant strains of Staphylococcus aureus in patients with endocarditis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284248

Teicoplanin, a new antibiotic from Actinoplanes teichomyceticus nov. sp.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284248

In vitro activity and human pharmacokinetics of teicoplanin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284248

Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284248

Comparative in vitro activities of teichomycin and vancomycin alone and in combination with rifampin and aminoglycosides against staphylococci and enterococci

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284248

In vitro activity of teichomycin compared with those of other antibiotics

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284248

Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284248

Therapeutic efficacy of teicoplanin in experimental enterococcal endocarditis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284248

Teicoplanin for patients allergic to vancomycin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284248

The use of a new glycopeptide antibiotic, teicoplanin, in the treatment of bacterial endocarditis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284248

Treatment of infections by staphylococci and other gram-positive bacteria with teicoplanin: an open study.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284248

Teicoplanin and rifampicin singly and in combination in the treatment of experimental Staphylococcus epidermidis endocarditis in the rabbit model.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284248

Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284248

Ototoxicity of teicoplanin in the guinea pig.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284248

Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284248

Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284248

Single or Combination Therapy of Staphylococcal Endocarditis in Intravenous Drug Abusers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284248

21 June 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/2527483

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparison of the solid phase enzyme receptor assay (SPERA) and the microbiological assay for teicoplanin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2527483

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

HPLC quantitation of the six main components of teicoplanin in biological fluids

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2527483

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.33.6.871

1 reference

29 July 2017

1 reference

29 July 2017

1 reference